Stewart William C, Day Douglas G, Jenkins Jessica N, Passmore Carla L, Stewart Jeanette A
Pharmaceutical Research Network, LLC, Charleston, SC 29407, USA.
J Ocul Pharmacol Ther. 2006 Feb;22(1):26-33. doi: 10.1089/jop.2006.22.26.
The aim of this study was to evaluate the association of corneal thickness on the incidence of glaucomatous progression at individual levels of intraocular pressure.
A retrospective, noninterventional evaluation of patients with primary open-angle glaucoma who were either stable over 5 years or had glaucomatous progression before 5 years of follow-up was performed. Each patient had central thickness corneal measurements documented.
We included 310 patients in this study. Patients with thicker (at least 0.571 mm, n = 77) and mid-range corneas (0.511-0.570 mm, n = 177) progressed in 14% (n = 11) and 18% (n = 31) of cases, respectively. The progression rate for patients with a mean pressure of less than 17 mmHg in both groups was 12%-13%. In contrast, the progression rate in patients with 18 mmHg or higher was 23% and 16% in the mid-range and thick corneal groups, respectively. In patients with thinner corneas (equal to or less than 0.510 mm, n = 56), the progression rate was 32% (n = 18). The progression rate was 60% (12 of 20) with mean pressures of at least 18 mmHg or higher, but 18% with mean pressures equal to or less than 17 mmHg. Univariant (P = 0.05), but not multivariant, analysis showed that corneal thickness was a risk factor for progression.
This study suggests that the reduction of intraocular pressure helps to prevent progression in patients with primary open-angle glaucoma. However, for patients with thinner corneas, pressure reduction may potentially be of even greater importance to help avoid glaucomatous progression. Future study should clarify potential variables associated with thin corneas and glaucomatous progression.
本研究旨在评估在个体眼压水平下,角膜厚度与青光眼病情进展发生率之间的关联。
对原发性开角型青光眼患者进行回顾性、非干预性评估,这些患者在5年期间病情稳定,或在随访5年之前出现青光眼病情进展。记录每位患者的中央角膜厚度测量值。
本研究纳入了310例患者。角膜较厚(至少0.571毫米,n = 77)和中等厚度角膜(0.511 - 0.570毫米,n = 177)的患者病情进展的发生率分别为14%(n = 11)和18%(n = 31)。两组中平均眼压低于17 mmHg的患者病情进展率为12% - 13%。相比之下,眼压为18 mmHg或更高的患者,中等厚度角膜组和厚角膜组的病情进展率分别为23%和16%。角膜较薄(等于或小于0.510毫米,n = 56)的患者病情进展率为32%(n = 18)。平均眼压至少为18 mmHg或更高时病情进展率为60%(20例中的12例),但平均眼压等于或低于17 mmHg时为18%。单因素分析(P = 0.05)显示角膜厚度是病情进展的危险因素,但多因素分析未显示此结果。
本研究表明,降低眼压有助于预防原发性开角型青光眼患者的病情进展。然而,对于角膜较薄的患者,降低眼压对于避免青光眼病情进展可能更为重要。未来的研究应阐明与薄角膜和青光眼病情进展相关的潜在变量。